- About ASEHA
- ASEHA Leaflet Series
- Air Quality Information
- Allergy Information
- Multiple Chemical Sensitivity
- Disability and Medical Issues For MCS and Allergy
- Children's Health Issues
- Web Links
- Search ASEHA
- ASEHA Press Releases
- ASEHA Submissions
- About Fragrances: Did you know.. Fragrances can make you ill.
- Chemical Sensitivity Leaflet
- Food, Mood And Behaviour
- Impacts Of Environmental Toxins On The Health Of Children
- Is It Really Migraine?
- Need to take a medication: some things you may need to consider.
- Pesticides They're Everywhere
- MCS Visitors Guidelines 2008
- Chemical Sensitivity: Is there a problem? : A Consumer Point of View
- Chemical Injury
- Multiple Chemical Sensitivity: A 1999 Consensus
- Disability Rights
- Disability Job Access in Australia
- Information on Applying For Low Allergy Housing
- Template Letter Applying For Low Allergy Housing
- Location, Housing Material and Design Guidelines
- Australian Human Rights and Equal Opportunity Commission
- Where To Find a Medical Practitioner
- Dealing with Hospitalisation and Emergency Surgery when Allergy, Food and Chemical Sensitivity are Complicating Factors.
- Health Information Template
- Australian Government Review of MCS 2006 -
- Fragrance, Perfume, Scent Information
- Formaldehyde in Clothing
- Medication Information
- Chemically sensitive! Dog got fleas!
- Medications for use with a Low Phenolic Diet
- MCS News
Multiple Chemical Sensitivity: 2006 Review of the Evidence
|MCS - ASEHA MCS Publications|
MULTIPLE CHEMICAL SENSITIVITY: 2006 Review of the Evidence
Prepared by Dr Sharyn Martin, PhD and Dorothy M. Bowes for ASEHA Qld Inc May 2006
This document was prepared in June 2006 by ASEHA representatives and MCS sufferers, Dorothy Bowes and Dr Sharyn Martin to provide an overview of the current state of knowledge of Multiple Chemical Sensitivity drawing on credible scientific and medical references. Incorporated are real problems and actual experiences that ASEHA has encountered through its advocacy work and communications with ASEHA members and the public. MCS has far reaching implications if left undiagnosed and untreated as it not only affects the health of the individual, it also affects that person and families lifestyle, financial situation, ability to socialise, ability to support oneself or family, ability to access and utilise facilities such as hospitals, schools, libraries, shopping centres, health care facilities etc.
ASEHA has prepared 16 recommendations, that we feel would progress the issues raised in this document. We have included the main issues for MCS sufferers from this document; the most urgent of these is access to appropriate medical practitioners and health care, hospitals and appropriate housing.
We feel that the body of scientific and medical evidence combined with personal experiences of MCS individuals to compel any Government to further research MCS and implement further measures to address chemical regulation and usage.
PART 1. EXPERIENCE AND DIAGNOSIS OF MCS
- Authoritative Evidence on the existence of MCS
- Specific symptoms and signs used to determine the presence of MCS
- Criteria health care providers (doctors and other practitioners) use to establish the diagnosis of MCS.
- Diagnostic tests used to confirm the diagnosis of MCS
- Factors contributing to the development of MCS.
- Prevalence of MCS.
- Factors influencing the apparent gender, workplace, ethnic and geographic differences in the prevalence of the diagnosis of MCS.
- The overlap between MCS and other chronic disorders such as CFS
PART 2. TREATMENT AND MANAGEMENT STRATEGIES FOR MCS
- Is MCS a treatable and/or manageable disorder
- Successful and unsuccessful strategies for treatment and management of MCS
- Goals for the treatment of MCS
- Factors that can influence the progression of MCS
- Can MCS be cured or controlled.
- Assistance needed in learning to live with MCS.
- Positive and Negative Factors that appear to influence the course of the condition
PART 3. RESEARCH AND EDUCATION
- Research being undertaken to improve the knowledge and understanding of MCS
- Gaps in knowledge associated with identifying and treating people who suffer from MCS
- Action being taken to overcome the education and knowledge gaps regarding MCS
- Strategies to improve or overcome gaps in education and knowledge about MCS And to assist in enabling people who suffer from this condition to be more effectively supported and understood
APPENDIX A. MCS Definitions
APPENDIX B. EHP Supplement Volume 105 Supplement 2, March 1997. Experimental Approaches to Chemical Sensitivity
APPENDIX C. Recommended guidance notes for physicians (Ashford & Miller. 1998).
APPENDIX D. MCS CASE HISTORIES
APPENDIX E. WHO Bangkok Charter for Health Promotion in a Globalised World:
|< Prev||Next >|
Last Updated (Monday, 16 November 2009 05:27)